{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:48:44Z","timestamp":1768582124371,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Huangpu International Science and Technology Collaboration Project","award":["2021GH08"],"award-info":[{"award-number":["2021GH08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04546-2","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:06:39Z","timestamp":1765177599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MSCohi-O lenses attenuate corneal transplant rejection via HLA-G5 driven Treg cell expansion"],"prefix":"10.1186","volume":"26","author":[{"given":"Yun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihua","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiexing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gene","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqi","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"2","key":"4546_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcyt.2024.10.008","volume":"27","author":"L Renesme","year":"2025","unstructured":"Renesme L, et al. Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics. Cytotherapy. 2025;27(2):146\u201368.","journal-title":"Cytotherapy"},{"issue":"12","key":"4546_CR2","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/sctm.17-0134","volume":"6","author":"M Shi","year":"2017","unstructured":"Shi M, et al. A pilot study of mesenchymal stem cell therapy for acute liver allograft rejection. Stem Cells Transl Med. 2017;6(12):2053\u201361.","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"4546_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/sctm.19-0185","volume":"9","author":"F Casiraghi","year":"2020","unstructured":"Casiraghi F, et al. Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration. Stem Cells Transl Med. 2020;9(4):427\u201332.","journal-title":"Stem Cells Transl Med"},{"key":"4546_CR4","doi-asserted-by":"crossref","unstructured":"Yao H et al. Sequential infusion of mesenchymal stem cell for graft-versus-host disease prevention in haploidentical hematopoietic stem cell transplantation: an open-label, multicenter, randomized controlled clinical trial. J Clin Oncol. 2025: p. JCO2402119.","DOI":"10.1200\/JCO-24-02119"},{"key":"4546_CR5","doi-asserted-by":"crossref","unstructured":"Liu Y et al. MSCohi-O lenses for long-term retention of mesenchymal stem cells on ocular surface as a therapeutic approach for chronic ocular graft-versus-host disease. Stem Cell Rep. 2023.","DOI":"10.1016\/j.stemcr.2023.10.010"},{"issue":"1","key":"4546_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13287-020-01852-y","volume":"11","author":"E Xiang","year":"2020","unstructured":"Xiang E, et al. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020;11(1):336.","journal-title":"Stem Cell Res Ther"},{"key":"4546_CR7","doi-asserted-by":"crossref","unstructured":"Zoehler B et al. HLA-G and CD152 expression levels encourage the use of umbilical cord tissue-derived mesenchymal stromal cells as an alternative for immunosuppressive therapy. Cells. 2022;11(8).","DOI":"10.3390\/cells11081339"},{"issue":"1","key":"4546_CR8","doi-asserted-by":"publisher","first-page":"8321","DOI":"10.1038\/s41598-024-59093-5","volume":"14","author":"M Song","year":"2024","unstructured":"Song M, et al. Umbilical cord mesenchymal stem cell-derived exosomes inhibits fibrosis in human endometrial stromal cells via miR-140-3p\/FOXP1\/Smad axis. Sci Rep. 2024;14(1):8321.","journal-title":"Sci Rep"},{"issue":"4","key":"4546_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.it.2017.01.009","volume":"38","author":"LMR Ferreira","year":"2017","unstructured":"Ferreira LMR, et al. HLA-G: at the interface of Maternal-Fetal tolerance. Trends Immunol. 2017;38(4):272\u201386.","journal-title":"Trends Immunol"},{"issue":"6","key":"4546_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00277-021-04486-z","volume":"100","author":"X Bu","year":"2021","unstructured":"Bu X, et al. Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2021;100(6):1391\u2013400.","journal-title":"Ann Hematol"},{"issue":"16","key":"4546_CR11","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1161\/01.CIR.0000015075.89984.46","volume":"105","author":"N Lila","year":"2002","unstructured":"Lila N, et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation. 2002;105(16):1949\u201354.","journal-title":"Circulation"},{"issue":"3","key":"4546_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/10408363.2012.677947","volume":"49","author":"A Gonzalez","year":"2012","unstructured":"Gonzalez A, et al. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci. 2012;49(3):63\u201384.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"4546_CR13","doi-asserted-by":"publisher","first-page":"788769","DOI":"10.3389\/fimmu.2021.788769","volume":"12","author":"A Lin","year":"2021","unstructured":"Lin A, Yan WH. Perspective of HLA-G induced immunosuppression in SARS-CoV-2 infection. Front Immunol. 2021;12:788769.","journal-title":"Front Immunol"},{"key":"4546_CR14","doi-asserted-by":"crossref","unstructured":"Zaborek-Lyczba M et al. The HLA-G immune checkpoint plays a pivotal role in the regulation of immune response in autoimmune diseases. Int J Mol Sci. 2021;22(24).","DOI":"10.3390\/ijms222413348"},{"issue":"23","key":"4546_CR15","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1007\/s00018-012-1069-3","volume":"69","author":"KY HoWangYin","year":"2012","unstructured":"HoWangYin KY, et al. Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors. Cell Mol Life Sci. 2012;69(23):4041\u20139.","journal-title":"Cell Mol Life Sci"},{"issue":"20","key":"4546_CR16","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1158\/1078-0432.CCR-12-3697","volume":"19","author":"G Curigliano","year":"2013","unstructured":"Curigliano G, et al. Molecular pathways: human leukocyte antigen G (HLA-G). Clin Cancer Res. 2013;19(20):5564\u201371.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"4546_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493\u2013507.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"4546_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12015-020-09960-1","volume":"16","author":"B Zoehler","year":"2020","unstructured":"Zoehler B, et al. Infusion of mesenchymal stem cells to treat graft versus host disease: the role of HLA-G and the impact of its polymorphisms. Stem Cell Rev Rep. 2020;16(3):459\u201371.","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"4546_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","volume":"84","author":"A Nasef","year":"2007","unstructured":"Nasef A, et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation. 2007;84(2):231\u20137.","journal-title":"Transplantation"},{"issue":"1","key":"4546_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","volume":"26","author":"Z Selmani","year":"2008","unstructured":"Selmani Z, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4\u2009+\u2009CD25highFOXP3\u2009+\u2009regulatory T cells. Stem Cells. 2008;26(1):212\u201322.","journal-title":"Stem Cells"},{"issue":"8","key":"4546_CR21","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1096\/fj.13-227264","volume":"27","author":"F Deschaseaux","year":"2013","unstructured":"Deschaseaux F, et al. Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue. FASEB J. 2013;27(8):2977\u201387.","journal-title":"FASEB J"},{"issue":"6","key":"4546_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/sctm.17-0305","volume":"7","author":"S Soontararak","year":"2018","unstructured":"Soontararak S, et al. Mesenchymal stem cells (MSC) derived from induced pluripotent stem cells (iPSC) equivalent to Adipose-Derived MSC in promoting intestinal healing and Microbiome normalization in mouse inflammatory bowel disease model. Stem Cells Transl Med. 2018;7(6):456\u201367.","journal-title":"Stem Cells Transl Med"},{"key":"4546_CR23","doi-asserted-by":"publisher","first-page":"100031","DOI":"10.1016\/j.gene.2020.100031","volume":"763S","author":"B Brinkhof","year":"2020","unstructured":"Brinkhof B, et al. ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation. Gene. 2020;763S:100031.","journal-title":"Gene"},{"key":"4546_CR24","doi-asserted-by":"crossref","unstructured":"Wang J et al. Manufacture and quality control of human umbilical cord-derived mesenchymal stem cell sheets for clinical use. Cells. 2022;11(17).","DOI":"10.3390\/cells11172732"},{"key":"4546_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cellimm.2016.01.002","volume":"302","author":"H Yang","year":"2016","unstructured":"Yang H, et al. Human umbilical cord-derived mesenchymal stem cells suppress proliferation of PHA-activated lymphocytes in vitro by inducing CD4(+)CD25(high)CD45RA(+) regulatory T cell production and modulating cytokine secretion. Cell Immunol. 2016;302:26\u201331.","journal-title":"Cell Immunol"},{"issue":"1","key":"4546_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00003226-200001000-00013","volume":"19","author":"N Koizumi","year":"2000","unstructured":"Koizumi N, et al. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea. 2000;19(1):65\u201371.","journal-title":"Cornea"},{"issue":"2","key":"4546_CR27","first-page":"222","volume":"8","author":"LT Hu","year":"2015","unstructured":"Hu LT, et al. TREM-1 expression in rat corneal epithelium with Aspergillus fumigatus infection. Int J Ophthalmol. 2015;8(2):222\u20137.","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"4546_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12886-018-0865-4","volume":"18","author":"YJ Kim","year":"2018","unstructured":"Kim YJ, et al. Clinical features and outcome of corneal opacity associated with congenital glaucoma. BMC Ophthalmol. 2018;18(1):190.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"4546_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s13287-025-04510-3","volume":"16","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, et al. TLR3-overexpressing umbilical cord mesenchymal stromal cells suppress immune responses to attenuate high-risk corneal transplantation rejection. Stem Cell Res Ther. 2025;16(1):370.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"4546_CR30","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1124\/dmd.116.069369","volume":"44","author":"J Lee","year":"2016","unstructured":"Lee J, Pelis RM. Drug transport by the Blood-Aqueous humor barrier of the eye. Drug Metab Dispos. 2016;44(10):1675\u201381.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"4546_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","volume":"24","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular drug delivery: a comprehensive review. AAPS PharmSciTech. 2023;24(2):66.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"4546_CR32","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/febs.16330","volume":"290","author":"F O\u2019Leary","year":"2023","unstructured":"O\u2019Leary F, Campbell M. The blood-retina barrier in health and disease. FEBS J. 2023;290(4):878\u201391.","journal-title":"FEBS J"},{"issue":"1","key":"4546_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000496809","volume":"46","author":"S Elgaz","year":"2019","unstructured":"Elgaz S, et al. Clinical use of mesenchymal stromal cells in the treatment of acute Graft-versus-Host disease. Transfus Med Hemother. 2019;46(1):27\u201334.","journal-title":"Transfus Med Hemother"},{"key":"4546_CR34","doi-asserted-by":"publisher","first-page":"761616","DOI":"10.3389\/fimmu.2021.761616","volume":"12","author":"K Kelly","year":"2021","unstructured":"Kelly K, Rasko JEJ. Mesenchymal stromal cells for the treatment of graft versus host disease. Front Immunol. 2021;12:761616.","journal-title":"Front Immunol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04546-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04546-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04546-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T02:02:49Z","timestamp":1768356169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-025-04546-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4546"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04546-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the protocols for the animal experiments followed the principles of the Laboratory Animal Welfare Act and were approved by the animal ethics committee of Zhongshan Ophthalmic Center Animal Care and Ethics Committee (approval number: O2023048).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}